FowkesFGRudanDRudanI, et al. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis. Lancet. 2013;382(9901):1329–1340. doi:10.1016/S0140-6736(13)61249-0.
2.
NakamaTWatanabeNHaraguchiT, et al. Clinical outcomes of pedal artery angioplasty for patients with ischemic wounds: results from the multicenter RENDEZVOUS registry. JACC Cardiovasc Interv. 2017;10(1):79–90. doi:10.1016/j.jcin.2016.10.025.
3.
JungHWKoYGHongSJ, et al. Editor’s choice—impact of endovascular pedal artery revascularisation on wound healing in patients with critical limb ischaemia. Eur J Vasc Endovasc Surg. 2019;58(6):854–863. doi:10.1016/j.ejvs.2019.07.034.
4.
MachinMYounanHCGuéroultAM, et al. Systematic review of inframalleolar endovascular interventions and rates of limb salvage, wound healing, restenosis, rest pain, reintervention and complications. Vascular. 2022;30(1):105–114. doi:10.1177/17085381211004246.
5.
MeloniMIzzoVGiuratoL, et al. Below-the-ankle arterial disease severely impairs the outcomes of diabetic patients with ischemic foot ulcers. Diabetes Res Clin Pract. 2019;152:9–15. doi:10.1016/j.diabres.2019.04.031.
6.
ConteMSBradburyAWKolhP, et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg. 2019;69(6S):3S–125S.e40. doi:10.1016/j.jvs.2019.02.016. Erratum in: J Vasc Surg. 2019;70(2):662.
7.
TASC Steering Committee;JaffMRWhiteCJHiattWR, et al. An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: a supplement to the inter-society consensus for the management of peripheral arterial disease (TASC II). Vasc Med. 2015;20(5):465–478. doi:10.1177/1358863X15597877.
8.
BradburyAWMoakesCAPopplewellM, et al. A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial. Lancet. 2023;401(10390):1798–1809. doi:10.1016/S0140-6736(23)00462-2.
9.
FarberAMenardMTConteMS, et al. Surgery or endovascular therapy for chronic limb-threatening ischemia. N Engl J Med. 2022;387(25):2305–2316. doi:10.1056/NEJMoa2207899.
10.
AttingerCEEvansKKBulanE, et al. Angiosomes of the foot and ankle and clinical implications for limb salvage: reconstruction, incisions, and revascularization. Plast Reconstr Surg. 2006;117(suppl 7):261S–293S.
11.
DilaverNTwineCPBosanquetDC.Editor’s choice—directvs. Indirect angiosomal revascularisation of infrapopliteal arteries, an updated systematic review and meta-analysis. Eur J Vasc Endovasc Surg. 2018;56(6):834–848.
12.
BiancariFJuvonenT.Angiosome-targeted lower limb revascularization for ischemic foot wounds: systematic review and meta-analysis. Eur J Vasc Endovasc Surg. 2014;47(5):517–522.
13.
KabraASureshKRVivekanandV, et al. Outcomes of angiosome and non-angiosome targeted revascularization in critical lower limb ischemia. J Vasc Surg. 2013;57(1):44–49. doi:10.1016/j.jvs.2012.07.042.
14.
AlexandrescuVABrochierSLimgbaA, et al. Healing of diabetic neuroischemic foot wounds with vs without wound-targeted revascularization: preliminary observations from an 8-year prospective dual-center registry. J Endovasc Ther. 2020;27(1):20–30. doi:10.1177/1526602819885131.
15.
BallottaEDa GiauGGruppoM, et al. Infrapopliteal arterial revascularization for critical limb ischemia: is the peroneal artery at the distal third a suitable outflow vessel?J Vasc Surg. 2008;47(5):952–959. doi:10.1016/j.jvs.2008.01.002.
16.
MohapatraABoitetAMalakO, et al. Peroneal bypass versus endovascular peroneal intervention for critical limb ischemia. J Vasc Surg. 2019;69(1):148–155. doi:10.1016/j.jvs.2018.04.049.
17.
SöderströmMAlbäckABiancariF, et al. Angiosome-targeted infrapopliteal endovascular revascularization for treatment of diabetic foot ulcers. J Vasc Surg. 2013;57(2):427–435. doi:10.1016/j.jvs.2012.07.057.
18.
SpillerovaKBiancariFLeppäniemiA, et al. Differential impact of bypass surgery and angioplasty on angiosome-targeted infrapopliteal revascularization. Eur J Vasc Endovasc Surg. 2015;49(4):412–419. doi:10.1016/j.ejvs.2014.12.023.
19.
NevilleRFAttingerCEBulanEJ, et al. Revascularization of a specific angiosome for limb salvage: does the target artery matter?Ann Vasc Surg. 2009;23(3):367–373. doi:10.1016/j.avsg.2008.08.022.
20.
AlexandrescuVAHubermontGPhilipsY, et al. Selective primary angioplasty following an angiosome model of reperfusion in the treatment of Wagner 1-4 diabetic foot lesions: practice in a multidisciplinary diabetic limb service. J Endovasc Ther. 2008;15(5):580–593. doi:10.1583/08-2460.1.
21.
VarelaCAcínFde HaroJ, et al. The role of foot collateral vessels on ulcer healing and limb salvage after successful endovascular and surgical distal procedures according to an angiosome model. Vasc Endovascular Surg. 2010;44(8):654–660.
22.
ZhengXTZengRCHuangJY, et al. The use of the angio- some concept for treating infrapopliteal critical limb ischemia through interventional therapy and determining the clinical significance of collateral vessels. Ann Vasc Surg. 2016;32:41–49.
23.
KawaradaOFujiharaMHigashimoriA, et al. Predictors of adverse clinical outcomes after successful infrapopliteal intervention. Catheter Cardiovasc Interv. 2012;80:861–871. doi:10.1002/ccd.24370.
24.
AlexandrescuVABrochierSSchoenenS, et al. Grades of below-the-ankle arterial occlusive disease following the angiosome perfusion: a new morphological assessment and correlations with the inframalleolar GVG stratification in CLTI patients. Ann Vasc Surg. 2022;81:358–377. doi:10.1016/j.avsg.2021.09.031.
25.
van den BergJC. Angiosome perfusion of the foot: an old theory or a new issue?Semin Vasc Surg. 2018;31(2–4):56–65. doi:10.1053/j.semvascsurg.2018.12.002.
26.
TroisiNTuriniFChisciE, et al. Pedal arch patency and not direct-angiosome revascularization predicts outcomes of endovascular interventions in diabetic patients with critical limb ischemia. Int Angiol. 2017;36(5):438–444. doi:10.23736/S0392-9590.17.03809-3.
27.
MustaphaJASaabFAMartinsenBJ, et al. Digital subtraction angiography prior to an amputation for critical limb ischemia (CLI): an expert recommendation statement from the CLI Global Society to Optimize Limb Salvage. J Endovasc Ther. 2020;27(4):540–546. doi:10.1177/1526602820928590.
28.
SchreuderSMNieuwdorpMKoelemayMJW, et al. Testing the sympathetic nervous system of the foot has a high predictive value for early amputation in patients with diabetes with a neuroischemic ulcer. BMJ Open Diabetes Res Care. 2018;6(1):e000592. doi:10.1136/bmjdrc-2018-000592.
29.
LiuIHWuBKrepkiyV, et al. Pedal arterial calcification score is associated with the risk of major amputation in chronic limb-threatening ischemia. J Vasc Surg. 2022;75(1):270–278.e3. doi:10.1016/j.jvs.2021.07.235.
30.
MisraSShishehborMHTakahashiEA, et al. Perfusion assessment in critical limb ischemia: principles for understanding and the development of evidence and evaluation of devices: a scientific statement from the American Heart Association. Circulation. 2019;140(12):e657–e672. doi:10.1161/CIR.0000000000000708.
31.
MenardMTFarberAAssmannSF, et al. Design and rationale of the best endovascular versus best surgical therapy for patients with critical limb ischemia (BEST-CLI) trial. J Am Heart Assoc. 2016;5(7):e003219. doi:10.1161/JAHA.116.003219.
32.
ChuterVSchaperNHinchliffeR, et al. Performance of non-invasive bedside vascular testing in the prediction of wound healing or amputation among people with foot ulcers in diabetes: a systematic review. Diabetes Metab Res Rev. 2024;40(3):e3701. doi:10.1002/dmrr.3701.
33.
TesoDSommersetJDallyM, et al. Pedal acceleration time (PAT): a novel predictor of limb salvage. Ann Vasc Surg. 2021;75:189–193. doi:10.1016/j.avsg.2021.02.038.
34.
Montero-BakerMFAu-YeungKYWisniewskiNA, et al. The First-in-Man “Si Se Puede” Study for the use of micro-oxygen sensors (MOXYs) to determine dynamic relative oxygen indices in the feet of patients with limb-threatening ischemia during endovascular therapy. J Vasc Surg. 2015;61(6):1501–1509.e1. doi:10.1016/j.jvs.2014.12.060.
35.
AwopetuAIGohelMSSadatU, et al. Clinical feasibility of diffuse speckle contrast analysis for real-time tissue perfusion monitoring. Int Angiol. 2022;41(1):82–89. doi:10.23736/S0392-9590.21.04740-4.
36.
IkeokaKWatanabeTShinodaY, et al. Below-the-ankle arrival time as a novel limb tissue perfusion index: two-dimensional perfusion angiography evaluation. J Endovasc Ther. 2020;27(2):198–204. doi:10.1177/1526602820905527.
37.
de Castro-SantosGGonçalvesPEOProcópioRJ, et al. Accuracy of the pedal acceleration time to diagnose limb ischemia in patients with and without diabetes using the WIfI classification. Vasc Med. 2023;28(1):36–44. doi:10.1177/1358863X221150453.
38.
TrihanJEMahéGCroquetteM, et al. Accuracy of acceleration time of distal arteries to diagnose severe peripheral arterial disease. Front Cardiovasc Med. 2022;8:744354. doi:10.3389/fcvm.2021.744354.
39.
TehanPE, et al. Diagnostic accuracy of pedal acceleration time for detecting peripheral arterial disease. PowerPoint presentation at 38th Western Vascular Society Annual Meeting;September10, 2023; Kauai, HI.
40.
MillsJLConteMSArmstrongDG, et al. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on Wound, Ischemia, and foot Infection (WIfI). J Vasc Surg. 2014;59(1):220–234.e1–e2.
41.
van ReijenNSPonchantKUbbinkDT, et al. Editor’s choice—the prognostic value of the WIfI classification in patients with chronic limb threatening ischaemia: a systematic review and meta-analysis. Eur J Vasc Endovasc Surg. 2019;58(3):362–371. doi:10.1016/j.ejvs.2019.03.040.
42.
FerraresiRClericiGCasiniA, et al. Foot angiosomes: instructions for use. Int J Low Extrem Wounds. 2020;19(4):293–304. doi:10.1177/1534734620954745.
43.
ManziMCesterGPalenaLM, et al. Vascular imaging of the foot: the first step toward endovascular recanalization. Radiographics. 2011;31(6):1623–1636. doi:10.1148/rg.316115511.
44.
AkturkAvan NettenJJVermeerM, et al. Improved outcomes in patients with diabetic foot ulcers despite of differences in baseline characteristics. Wound Repair Regen. 2021;29(6):912–919. doi:10.1111/wrr.12976.